Knowledge Community Insider




Aggie Square Development In Sacramento Spurs Other Projects

The mixed-use innovation district will add 1.2 million square-feet of research, wet labs, commercial space and housing.


Doug Woodruff with Wexford Science & Technology is overseeing the project.

“The goal of this is to advance a lot of that research but also to bring into the market—companies and capital that want to invest in that research to make it commercialized,” Woodruff said.

Good Day Sacramento   |   December 1, 2021

Read More

The Commons Podcast

Episodes 7 and 8 of Season 2 are now available. Our host, Tom Osha, interviews Jonathan Bates from the University of Utah and Laura Frerichs from the University of Illinois.

Listen Here

Science Center’s new $4M federal grant will bring STEM education to 300+ kids

Amid the ongoing push from University City institutions to get more Philadelphians into STEM careers, University City Science Center’s STEM education program for teens is the recipient of nearly $4 million from the US Department of Education, the org announced this week. Philly   |   December 21, 2021

Read More

Phoenix bioscience startup secures $50M to kill cancer using a rabbit virus

Phoenix-based OncoMyx Therapeutics has received $50 million in funding to be used to develop cancer killing agents using a virus found in rabbits.

This series B funding round follows $25 million in series A financing the company received in 2019 after spinning out from Arizona State University in 2018.

AZ Inno  |   December 8, 2021

Read More

How GDIT is advancing St. Louis’s geospatial sector through innovation


When General Dynamics Information Technology (GDIT) cut the ribbon on its new headquarters in the Cortex Innovation Community on Dec. 13, it did much more than welcome its growing St. Louis workforce into a fresh space; it launched an innovative new lab designed to deliver best-in-class solutions to the intelligence and technology community.

St. Louis Business Journal  |  December 16, 2021 (Subscription needed to read full article)

Read More

This university startup found strong support and space without leaving town

Biomedical innovations can take a decade or more of ongoing research and development before they are ready to be used to treat patients. Even with funding and expert scientists, the most promising technologies can fail to go to market if entrepreneurs don’t have the experience or support to navigate the long and tedious drug development process. Baltimore   |   November 29, 2021

Read More

How one high-tech Philly industry may be the future of medicine and create lots of jobs

First came decades of research, full of setbacks. Then lab work slowly resumed, culminating in the first drug approval in 2017, followed by two more.

Now more than 40 companies in the Philadelphia region are working in cell and gene therapy, producing a stream of new jobs and even a run on lab space.

Gene therapy, a technology to replace defective genes that cause incurable diseases with new ones, is having its moment in medicine. And Philadelphia, birthplace of many firsts in health care, has been the cradle of this one as well.

The Philadelphia Inquirer  |   November 23, 2021

Read More

Axios Charlotte
December 9, 2021


Most anticipated Charlotte developments breaking ground in 2022



Read More

St. Louis Post Dispatch
December 16, 2021


Two companies pick Cortex for expansion






Read More

The News & Observer
December 3, 2021

Matt Kane steered his last biotech to an IPO. He’s back with a new startup and $40M




Read More

Copyright ©2021 Wexford Science & Technology, LLC , All rights reserved.